Phreesia, Inc. (NYSE:PHR) Receives $31.62 Consensus Target Price from Analysts

Phreesia, Inc. (NYSE:PHR) has earned an average rating of “Moderate Buy” from the fourteen analysts that are presently covering the company, MarketBeat.com reports. Two equities research analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company. The average twelve-month price target among brokerages that have covered the stock in the last year is $31.62.

Several research firms recently weighed in on PHR. Truist Financial began coverage on Phreesia in a research report on Monday, February 26th. They set a “buy” rating and a $35.00 price objective for the company. Stephens restated an “overweight” rating and set a $28.00 price target on shares of Phreesia in a research note on Friday, March 22nd. JMP Securities boosted their price target on Phreesia from $28.00 to $30.00 and gave the company a “market outperform” rating in a research note on Thursday, March 21st. DA Davidson restated a “neutral” rating and set a $32.00 price target on shares of Phreesia in a research note on Friday, March 15th. Finally, Robert W. Baird boosted their price target on Phreesia from $30.00 to $31.00 and gave the company an “outperform” rating in a research note on Monday, March 18th.

Phreesia Price Performance

Shares of NYSE:PHR opened at $22.41 on Tuesday. Phreesia has a fifty-two week low of $12.05 and a fifty-two week high of $34.98. The business has a 50-day moving average of $24.15 and a two-hundred day moving average of $21.36. The stock has a market capitalization of $1.26 billion, a P/E ratio of -8.89 and a beta of 0.92. The company has a debt-to-equity ratio of 0.02, a current ratio of 1.78 and a quick ratio of 1.78.

Phreesia (NYSE:PHR) last announced its quarterly earnings results on Thursday, March 14th. The company reported ($0.56) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.58) by $0.02. Phreesia had a negative return on equity of 53.33% and a negative net margin of 38.42%. The company had revenue of $95.00 million during the quarter, compared to analysts’ expectations of $93.52 million. During the same quarter in the previous year, the firm earned ($0.72) earnings per share. The business’s quarterly revenue was up 24.0% compared to the same quarter last year. On average, equities research analysts predict that Phreesia will post -1.48 EPS for the current fiscal year.

Insider Buying and Selling

In related news, insider Janet Gunzburg sold 2,817 shares of the stock in a transaction that occurred on Tuesday, March 19th. The stock was sold at an average price of $23.27, for a total transaction of $65,551.59. Following the sale, the insider now directly owns 40,609 shares in the company, valued at approximately $944,971.43. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. In other Phreesia news, COO Evan Roberts sold 25,962 shares of the company’s stock in a transaction on Thursday, March 21st. The stock was sold at an average price of $23.52, for a total transaction of $610,626.24. Following the transaction, the chief operating officer now owns 728,570 shares of the company’s stock, valued at approximately $17,135,966.40. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Also, insider Janet Gunzburg sold 2,817 shares of the company’s stock in a transaction on Tuesday, March 19th. The stock was sold at an average price of $23.27, for a total value of $65,551.59. Following the transaction, the insider now directly owns 40,609 shares in the company, valued at approximately $944,971.43. The disclosure for this sale can be found here. Insiders have sold a total of 82,989 shares of company stock worth $1,911,735 in the last three months. Insiders own 5.80% of the company’s stock.

Institutional Inflows and Outflows

Several large investors have recently bought and sold shares of the company. Diversified Trust Co acquired a new position in shares of Phreesia in the 1st quarter valued at $256,000. WoodTrust Financial Corp lifted its stake in shares of Phreesia by 87.9% in the 1st quarter. WoodTrust Financial Corp now owns 31,000 shares of the company’s stock valued at $742,000 after purchasing an additional 14,500 shares during the period. Moody National Bank Trust Division lifted its stake in shares of Phreesia by 41.9% in the 1st quarter. Moody National Bank Trust Division now owns 71,044 shares of the company’s stock valued at $1,700,000 after purchasing an additional 20,977 shares during the period. Vanguard Group Inc. lifted its stake in shares of Phreesia by 4.4% in the 4th quarter. Vanguard Group Inc. now owns 4,628,441 shares of the company’s stock valued at $107,148,000 after purchasing an additional 194,035 shares during the period. Finally, Ophir Asset Management Pty Ltd lifted its stake in shares of Phreesia by 24.1% in the 4th quarter. Ophir Asset Management Pty Ltd now owns 1,099,505 shares of the company’s stock valued at $25,454,000 after purchasing an additional 213,805 shares during the period. Institutional investors and hedge funds own 92.10% of the company’s stock.

Phreesia Company Profile

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.